Damico B. Jennifer's most recent trade in Pfizer Inc. was a trade of 47,511 Stock Appreciation Rights done . Disclosure was reported to the exchange on Feb. 27, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Pfizer | Jennifer B. Damico | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 47,511 | 47,511 | - | - | Stock Appreciation Rights | |
| Pfizer | Jennifer B. Damico | SVP & Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 22,416 | 0 | - | - | Stock Appreciation Rights | |
| Pfizer | Jennifer B. Damico | SVP & Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 31.31 per share. | 27 Feb 2025 | 22,416 | 31,063 (0%) | 0% | 31.3 | 701,845 | Common Stock |
| Pfizer | Jennifer B. Damico | SVP & Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.06 per share. | 27 Feb 2025 | 20,994 | 9,516 (0%) | 0% | 26.1 | 547,104 | Common Stock |
| Pfizer | Jennifer B. Damico | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 5,583 | 14,350 (0%) | 0% | 0 | Common Stock | |
| Pfizer | Jennifer B. Damico | SVP & Controller | Sale of securities on an exchange or to another person at price $ 25.93 per share. | 27 Feb 2025 | 2,500 | 11,850 (0%) | 0% | 25.9 | 64,825 | Common Stock |
| Pfizer | Jennifer B. Damico | SVP & Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.10 per share. | 27 Feb 2025 | 749 | 29,761 (0%) | 0% | 26.1 | 19,549 | Common Stock |
| Pfizer | Jennifer B. Damico | SVP & Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.10 per share. | 27 Feb 2025 | 553 | 30,510 (0%) | 0% | 26.1 | 14,433 | Common Stock |
| Pfizer | Jennifer B. Damico | SVP & Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.17 per share. | 22 Feb 2025 | 8,741 | 17,602 (0%) | 0% | 30.2 | 263,716 | Common Stock |
| Pfizer | Jennifer B. Damico | SVP & Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2025 | 8,741 | 0 | - | - | Stock Appreciation Rights | |
| Pfizer | Jennifer B. Damico | SVP & Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.08 per share. | 22 Feb 2025 | 7,798 | 9,414 (0%) | 0% | 26.1 | 203,372 | Common Stock |
| Pfizer | Jennifer B. Damico | SVP & Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.30 per share. | 22 Feb 2025 | 390 | 9,024 (0%) | 0% | 26.3 | 10,257 | Common Stock |
| Pfizer | Jennifer B. Damico | SVP & Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.30 per share. | 22 Feb 2025 | 390 | 17,212 (0%) | 0% | 26.3 | 10,257 | Common Stock |
| Pfizer | Jennifer B. Damico | SVP & Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.65 per share. | 22 Feb 2025 | 377 | 8,647 (0%) | 0% | 26.6 | 10,047 | Common Stock |
| Pfizer | Jennifer B. Damico | SVP & Controller | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Sep 2024 | 12,169 | 0 | - | - | Stock Appreciation Rights | |
| Pfizer | Jennifer B. Damico | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2024 | 12,169 | 12,169 | - | - | Stock Appreciation Rights | |
| Pfizer | Jennifer B. Damico | SVP & Controller | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Sep 2024 | 11,623 | 0 | - | - | Stock Appreciation Rights | |
| Pfizer | Jennifer B. Damico | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2024 | 11,623 | 11,623 | - | - | Stock Appreciation Rights | |
| Pfizer | Jennifer B. Damico | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2024 | 52 | 29,312 | - | - | Phantom Stock Units SSP | |
| Pfizer | Jennifer B. Damico | SVP & Controller | Sale of securities on an exchange or to another person at price $ 28.66 per share. | 13 Aug 2024 | 5,154 | 8,582 (0%) | 0% | 28.7 | 147,714 | Common Stock |
| Pfizer | Jennifer B. Damico | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jul 2024 | 49 | 29,223 | - | - | Phantom Stock Units SSP | |
| Pfizer | Jennifer B. Damico | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2024 | 52 | 28,794 | - | - | Phantom Stock Units SSP | |
| Pfizer | Jennifer B. Damico | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2024 | 222 | 28,745 | - | - | Phantom Stock Units SSP | |
| Pfizer | Jennifer B. Damico | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2024 | 54 | 28,525 | - | - | Phantom Stock Units SSP | |
| Pfizer | Jennifer B. Damico | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 51 | 28,475 | - | - | Phantom Stock Units SSP | |
| Pfizer | Jennifer B. Damico | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 49 | 28,397 | - | - | Phantom Stock Units SSP | |
| Pfizer | Jennifer B. Damico | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 49 | 28,346 | - | - | Phantom Stock Units SSP | |
| Pfizer | Jennifer B. Damico | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2024 | 55 | 27,920 | - | - | Phantom Stock Units SSP | |
| Pfizer | Jennifer B. Damico | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2024 | 54 | 27,864 | - | - | Phantom Stock Units SSP | |
| Pfizer | Jennifer B. Damico | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2024 | 108 | 27,806 | - | - | Phantom Stock Units SSP | |
| Pfizer | Jennifer B. Damico | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2024 | 49 | 27,686 | - | - | Phantom Stock Units SSP | |
| Pfizer | Jennifer B. Damico | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 87 | 27,635 | - | - | Phantom Stock Units SSP | |
| Pfizer | B. Jennifer Damico | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 19,697 | 19,697 | - | - | Stock Appreciation Rights | |
| Pfizer | B. Damico Jennifer | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 17,404 | 17,404 | - | - | Stock Appreciation Rights | |
| Pfizer | B. Jennifer Damico | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 5,113 | 13,495 (0%) | 0% | 0 | Common Stock | |
| Pfizer | Jennifer Damico B. | SVP & Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.34 per share. | 23 Feb 2024 | 9,752 | 19,228 (0%) | 0% | 27.3 | 266,620 | Common Stock |
| Pfizer | Jennifer B. Damico | SVP & Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 9,752 | 0 | - | - | Stock Appreciation Rights | |
| Pfizer | B. Damico Jennifer | SVP & Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.37 per share. | 23 Feb 2024 | 7,881 | 10,122 (0%) | 0% | 27.4 | 215,703 | Common Stock |
| Pfizer | Jennifer Damico B. | SVP & Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.76 per share. | 23 Feb 2024 | 1,386 | 8,382 (0%) | 0% | 27.8 | 38,475 | Common Stock |
| Pfizer | Damico B. Jennifer | SVP & Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.76 per share. | 23 Feb 2024 | 774 | 18,003 (0%) | 0% | 27.8 | 21,486 | Common Stock |
| Pfizer | Damico Jennifer B. | SVP & Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.76 per share. | 23 Feb 2024 | 451 | 18,777 (0%) | 0% | 27.8 | 12,520 | Common Stock |
| Pfizer | Damico B. Jennifer | SVP & Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.76 per share. | 23 Feb 2024 | 354 | 9,768 (0%) | 0% | 27.8 | 9,827 | Common Stock |
| Pfizer | B. Damico Jennifer | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 3,493 | 27,560 | - | - | Phantom Stock Units SSP | |
| Pfizer | Jennifer B. Damico | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2024 | 214 | 23,693 | - | - | Phantom Stock Units SSP | |
| Pfizer | Jennifer Damico B. | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2023 | 47 | 23,475 | - | - | Phantom Stock Units SSP | |
| Pfizer | Jennifer B. Damico | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2023 | 51 | 23,444 | - | - | Phantom Stock Units SSP | |
| Pfizer | B. Damico Jennifer | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2023 | 44 | 23,362 | - | - | Phantom Stock Units SSP | |
| Pfizer | Jennifer B. Damico | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2023 | 45 | 23,319 | - | - | Phantom Stock Units SSP | |
| Pfizer | Jennifer B. Damico | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2023 | 44 | 22,959 | - | - | Phantom Stock Units SSP | |
| Pfizer | Jennifer B. Damico | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Oct 2023 | 42 | 22,912 | - | - | Phantom Stock Units SSP | |
| Pfizer | Jennifer B. Damico | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Oct 2023 | 184 | 22,863 | - | - | Phantom Stock Units SSP | |
| Pfizer | Jennifer B. Damico | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Sep 2023 | 41 | 22,681 | - | - | Phantom Stock Units SSP | |
| Pfizer | Jennifer B. Damico | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2023 | 40 | 22,636 | - | - | Phantom Stock Units SSP | |
| Pfizer | Jennifer B. Damico | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2023 | 38 | 22,594 | - | - | Phantom Stock Units SSP | |
| Pfizer | Jennifer B. Damico | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2023 | 38 | 22,555 | - | - | Phantom Stock Units SSP | |
| Pfizer | Jennifer B. Damico | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jul 2023 | 37 | 22,509 | - | - | Phantom Stock Units SSP | |
| Pfizer | Jennifer B. Damico | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jul 2023 | 169 | 22,182 | - | - | Phantom Stock Units SSP | |
| Pfizer | Jennifer B. Damico | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jul 2023 | 37 | 22,219 | - | - | Phantom Stock Units SSP | |
| Pfizer | Jennifer B. Damico | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 37 | 22,012 | - | - | Phantom Stock Units SSP | |
| Pfizer | Jennifer B. Damico | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 34 | 21,962 | - | - | Phantom Stock Units SSP | |
| Pfizer | Jennifer B. Damico | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 36 | 21,942 | - | - | Phantom Stock Units SSP | |
| Pfizer | Jennifer B. Damico | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2023 | 36 | 21,913 | - | - | Phantom Stock Units SSP | |
| Pfizer | Jennifer B. Damico | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2023 | 35 | 21,633 | - | - | Phantom Stock Units SSP | |
| Pfizer | Jennifer B. Damico | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Apr 2023 | 33 | 21,590 | - | - | Phantom Stock Units SSP | |
| Pfizer | Jennifer B. Damico | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Apr 2023 | 353 | 21,556 | - | - | Phantom Stock Units SSP | |
| Pfizer | Jennifer B. Damico | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 32 | 21,206 | - | - | Phantom Stock Units SSP | |
| Pfizer | Jennifer B. Damico | SVP & Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2023 | 11,150 | 0 | - | - | Stock Appreciation Rights | |
| Pfizer | Jennifer B. Damico | SVP & Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.89 per share. | 25 Feb 2023 | 11,150 | 27,893 (0%) | 0% | 22.9 | 255,224 | Common Stock |
| Pfizer | Jennifer B. Damico | SVP & Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.44 per share. | 25 Feb 2023 | 4,958 | 20,702 (0%) | 0% | 43.4 | 215,376 | Common Stock |
| Pfizer | Jennifer B. Damico | SVP & Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.75 per share. | 25 Feb 2023 | 2,233 | 25,660 (0%) | 0% | 41.8 | 93,228 | Common Stock |
| Pfizer | Jennifer B. Damico | SVP & Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.78 per share. | 25 Feb 2023 | 1,427 | 19,275 (0%) | 0% | 40.8 | 58,193 | Common Stock |
| Pfizer | Jennifer B. Damico | SVP & Controller | Sale of securities on an exchange or to another person at price $ 40.02 per share. | 24 Feb 2023 | 9,912 | 9,003 (0%) | 0% | 40.0 | 396,678 | Common Stock |
| Pfizer | Jennifer B. Damico | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2023 | 451 | 21,176 | - | - | Phantom Stock Units SSP | |
| Pfizer | Jennifer B. Damico | SVP & Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.75 per share. | 24 Feb 2023 | 360 | 16,383 (0%) | 0% | 41.8 | 15,030 | Common Stock |
| Pfizer | Jennifer B. Damico | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2023 | 12,169 | 12,169 | - | - | Stock Appreciation Rights | |
| Pfizer | Jennifer B. Damico | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2023 | 10,591 | 10,591 | - | - | Stock Appreciation Rights | |
| Pfizer | Jennifer B. Damico | SVP & Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.17 per share. | 22 Feb 2023 | 10,456 | 21,584 (0%) | 0% | 30.2 | 315,458 | Common Stock |
| Pfizer | Jennifer B. Damico | SVP & Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2023 | 10,456 | 0 | - | - | Stock Appreciation Rights | |
| Pfizer | Jennifer B. Damico | SVP & Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.70 per share. | 22 Feb 2023 | 6,365 | 13,640 (0%) | 0% | 43.7 | 278,151 | Common Stock |
| Pfizer | Jennifer B. Damico | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2023 | 3,103 | 16,743 (0%) | 0% | 0 | Common Stock | |
| Pfizer | Jennifer B. Damico | SVP & Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.38 per share. | 22 Feb 2023 | 1,579 | 20,005 (0%) | 0% | 42.4 | 66,918 | Common Stock |
| Pfizer | Jennifer B. Damico | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 1,488 | 20,707 | - | - | Phantom Stock Units SSP | |
| Pfizer | Jennifer B. Damico | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2023 | 121 | 19,021 | - | - | Phantom Stock Units SSP | |
| Pfizer | Jennifer B. Damico | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Dec 2022 | 25 | 18,889 | - | - | Phantom Stock Units SSP | |
| Pfizer | Jennifer B. Damico | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2022 | 24 | 18,857 | - | - | Phantom Stock Units SSP | |
| Pfizer | Jennifer B. Damico | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2022 | 26 | 18,841 | - | - | Phantom Stock Units SSP | |
| Pfizer | Jennifer B. Damico | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2022 | 27 | 18,824 | - | - | Phantom Stock Units SSP | |
| Pfizer | Jennifer B. Damico | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2022 | 28 | 18,649 | - | - | Phantom Stock Units SSP | |
| Pfizer | Jennifer B. Damico | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Oct 2022 | 30 | 18,631 | - | - | Phantom Stock Units SSP | |
| Pfizer | Jennifer B. Damico | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Oct 2022 | 138 | 18,604 | - | - | Phantom Stock Units SSP | |
| Pfizer | Jennifer B. Damico | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2022 | 29 | 18,461 | - | - | Phantom Stock Units SSP | |
| Pfizer | Jennifer B. Damico | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2022 | 28 | 18,425 | - | - | Phantom Stock Units SSP | |
| Pfizer | Jennifer B. Damico | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2022 | 28 | 18,404 | - | - | Phantom Stock Units SSP | |
| Pfizer | Jennifer B. Damico | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2022 | 26 | 18,348 | - | - | Phantom Stock Units SSP | |
| Pfizer | Jennifer B. Damico | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2022 | 25 | 18,322 | - | - | Phantom Stock Units SSP | |
| Pfizer | Jennifer B. Damico | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2022 | 25 | 18,150 | - | - | Phantom Stock Units SSP | |
| Pfizer | Jennifer B. Damico | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jul 2022 | 112 | 18,124 | - | - | Phantom Stock Units SSP | |
| Pfizer | Jennifer B. Damico | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2022 | 25 | 18,010 | - | - | Phantom Stock Units SSP | |
| Pfizer | Jennifer B. Damico | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 27 | 17,993 | - | - | Phantom Stock Units SSP | |
| Pfizer | Jennifer B. Damico | SVP & Controller | Sale of securities on an exchange or to another person at price $ 53.96 per share. | 07 Jun 2022 | 4,218 | 10,846 (0%) | 0% | 54.0 | 227,603 | Common Stock |
| Pfizer | Jennifer B. Damico | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2022 | 24 | 17,946 | - | - | Phantom Stock Units SSP |